Page 115 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
yoz M, Álvarez-Gigli L, Abengozar-Muela M, Sáez-Ochoa B, Newton PT, Tegner J, Paiva
B, Martínez-Climent JA, Gómez-Cabrero D, Prósper F.
• A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent in
Multiple Myeloma Patients Relapsed and/or Refractory (RRMM) to Anti-CD38 Mono-
clonal Antibodies (mAbs).
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023, San Diego,
CA, USA. Blood. 2023;142(Supplement 1):1921. https://doi.org/10.1182/blood-2023-182150.
Zabaleta A, Blanco L, Kim P, Bisht K, Wang H, Van de Velde HJ, Lasa M, Tamariz-Amador
LE, Rodríguez Otero P, San Miguel J, Paiva B, Martín-Sánchez E.
• Sustained Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during
Maintenance Discriminates Patients with Sustained Negative Minimal Residual Dis-
ease.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023, San Diego,
CA, USA. Blood. 2023;142(Supplement 1):1958. https://doi.org/10.1182/blood-2023-179452.
Lakhwani S, Rosiñol L, Puig N, Pico Picos MA, Medina-González L, Martínez López J, Paiva
B, Cedena Romero MT, Oriol A, Ríos R, Blanchard MJ, Jarque I, Bargay J, Moraleda JM,
Carrillo-Cruz E, Sureda Balari AM, Krsnik I, González García E, Casado Montero LF, Marti
Tutusaus JM, Encinas Rodríguez C, De Arriba F, Palomera L, Sampol Mayol A, González-
Montes Y, Motlló C, De la Cruz J, Alonso Fernández R, Mateos MV, Bladé Creixenti J,
Lahuerta Palacios JJ, San Miguel J, Hernández García MT.
• Multiomics Characterization of Normal CD34+ Hematopoietic Progenitor Cells (HPC)
and Blasts in the Bone Marrow (BM) and Peripheral Blood (PB) of Patients with Acute
Myeloid Leukemia (AML).
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023, San Diego,
CA, USA. Blood. 2023;142(Supplement 1):2951. https://doi.org/10.1182/blood-2023-185760.
Simoes C, González C, Burgos L, Sarvide S, Alignani D, López A, Quispe I, Pérez-Simón
JA, García-Fortes M, Bernal Del Castillo T, Colorado M, Olave T, Alfonso Piérola A, Prós-
per F, Montesinos P, Paiva B.
• Intracytoplasmatic BCMA Point Mutation and Teclistamab Resistance: Genomic As-
sessment of a Multidrug-Resistant Multiple Myeloma Patient.
65th ASH Annual Meeting and Exposition 2023 (ASH 2023). 09-12 Dec 2023, San Diego,
CA, USA. Blood. 2023;142(Supplement 1):1925. https://doi.org/10.1182/blood-2023-184824.
Buenache Cuenda N, Cuesta Hernández HN, Giménez Sánchez A, Carneros Blanco L,
Rosa-Rosa JM, Ruiz-Heredia J, Revilla E, Han S, Munawar U, Rapado I, Ayala R, Kortüm
KM, Valeri A, Barrio S, Martínez López J, Haertle L.
115